0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
447.27%
Operating income growth above 1.5x 0425.HK's 10.86%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-240.38%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-240.64%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-240.64%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.29%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.29%
Reduced diluted shares while 0425.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.29%
Similar dividend growth to 0425.HK's 0.31%. Walter Schloss might see parallel free cash flow or payout philosophies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
36886.77%
10Y revenue/share CAGR above 1.5x 0425.HK's 588.47%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
77774.65%
5Y revenue/share CAGR above 1.5x 0425.HK's 385.68%. David Dodd would look for consistent product or market expansions fueling outperformance.
49695.23%
3Y revenue/share CAGR above 1.5x 0425.HK's 130.80%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-1313.32%
Negative 10Y OCF/share CAGR while 0425.HK stands at 1368.36%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-579.30%
Negative 5Y OCF/share CAGR while 0425.HK is at 211.29%. Joel Greenblatt would question the firm’s operational model or cost structure.
-2099.45%
Negative 3Y OCF/share CAGR while 0425.HK stands at 104.96%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-993.88%
Negative 10Y net income/share CAGR while 0425.HK is at 406.81%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-1437.92%
Negative 5Y net income/share CAGR while 0425.HK is 281.93%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-678.14%
Negative 3Y CAGR while 0425.HK is 84.17%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.16%
AR growth of 4.16% while 0425.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
35.28%
Inventory growth well above 0425.HK's 26.66%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
19.16%
Similar asset growth to 0425.HK's 19.21%. Walter Schloss finds parallel expansions or investment rates.
6.99%
50-75% of 0425.HK's 12.75%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
10.37%
Debt shrinking faster vs. 0425.HK's 108.03%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.